Novo Holdings A/S

Insider Reports History

Location
Hellerup
Signature
/s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Novo Holdings A/S:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. 10%+ Owner COMMON STOCK 4,016,878 $222,004,412 $55.27 08 Feb 2022 Direct
Edgewise Therapeutics, Inc. 10%+ Owner COMMON STOCK 6,071,703 $95,781,722 $15.78 14 Sep 2022 Direct
Disc Medicine, Inc. 10%+ Owner Common Stock 1,090,772 $73,790,726 $67.65 28 Jun 2023 Direct
Checkmate Pharmaceuticals, Inc. 10%+ Owner Common Stock 2,161,990 $22,592,579 $10.45 25 Feb 2022 Direct
Reneo Pharmaceuticals, Inc. 10%+ Owner Common Stock 3,330,337 $20,900,196 $6.28 23 Jun 2023 Direct
Inogen Inc 10%+ Owner COMMON STOCK 2,079,320 $11,893,710 $5.72 02 Jun 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner COMMON STOCK 793,265 $7,932,650 $10.00 21 Jun 2021 Direct
Cyteir Therapeutics, Inc. 10%+ Owner Common Stock 3,522,136 $5,952,410 $1.69 20 Jul 2023 Direct
IO Biotech, Inc. 10%+ Owner COMMON STOCK 4,354,449 $5,709,989 $1.31 26 Jul 2024 Direct
Metagenomi, Inc. 10%+ Owner COMMON STOCK 1,739,175 $5,008,824 $2.88 13 Feb 2024 Direct
Bolt Biotherapeutics, Inc. 10%+ Owner COMMON STOCK 3,703,991 $3,518,791 $0.9500 13 Jul 2022 Direct
SPRUCE BIOSCIENCES, INC. 10%+ Owner COMMON STOCK 2,550,000 $1,924,485 $0.7547 21 Mar 2024 Direct
MINERVA SURGICAL INC 10%+ Owner COMMON STOCK 2,057,132 $420,889 $0.2046 26 Oct 2021 Direct
MapLight Therapeutics, Inc. 10%+ Owner Voting Common Stock 3,686,622 28 Oct 2025 Direct
IO Biotech, Inc. 10%+ Owner Common Stock Warrant (Right to Buy) 2,469,135 09 Aug 2023 Direct
Arcellx, Inc. 10%+ Owner SERIES A PREFERRED STOCK 0 08 Feb 2022 Direct
Arcellx, Inc. 10%+ Owner SERIES B-1 PREFERRED STOCK 0 08 Feb 2022 Direct
Arcellx, Inc. 10%+ Owner SERIES B-2 PREFERRED STOCK 0 08 Feb 2022 Direct
Arcellx, Inc. 10%+ Owner SERIES C PREFERRED STOCK 0 08 Feb 2022 Direct
MapLight Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 28 Oct 2025 Direct
MapLight Therapeutics, Inc. 10%+ Owner Series D Preferred Stock 0 28 Oct 2025 Direct
Metagenomi, Inc. 10%+ Owner SERIES B-1 PREFERRED STOCK 0 13 Feb 2024 Direct
Metagenomi, Inc. 10%+ Owner SERIES B PREFERRED STOCK 0 13 Feb 2024 Direct
MINERVA SURGICAL INC 10%+ Owner SERIES D REDEEMABLE CONVERTIBLE PREFERRED STOCK 0 26 Oct 2021 Direct
MINERVA SURGICAL INC 10%+ Owner SUBORDINATED SECURED CONVERTIBLE PROMISSORY NOTES 0 26 Oct 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner SERIES B CONVERTIBLE PREFERRED STOCK 0 21 Jun 2021 Direct

Insider Reports Filed by Novo Holdings A/S

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MPLT MapLight Therapeutics, Inc. 28 Oct 2025 4 +$16,199,997 4 10%+ Owner 30 Oct 2025, 16:31
MPLT MapLight Therapeutics, Inc. 25 Oct 2025 0 $0 3 10%+ Owner 27 Oct 2025, 17:00
IOBT IO Biotech, Inc. 25 Jul 2024 2 -$99,125 4 10%+ Owner 26 Jul 2024, 21:22
IOBT IO Biotech, Inc. 10 May 2024 1 -$802,495 4 10%+ Owner 14 May 2024, 21:13
SPRB SPRUCE BIOSCIENCES, INC. 21 Mar 2024 1 -$350,951 4 10%+ Owner 25 Mar 2024, 21:45
SPRB SPRUCE BIOSCIENCES, INC. 18 Mar 2024 3 -$1,358,804 4 10%+ Owner 20 Mar 2024, 20:56
SPRB SPRUCE BIOSCIENCES, INC. 14 Mar 2024 1 -$1,698,902 4 10%+ Owner 18 Mar 2024, 21:14
MGX Metagenomi, Inc. 09 Feb 2024 5 +$13,025,000 4 10%+ Owner 15 Feb 2024, 20:38
IOBT IO Biotech, Inc. 09 Feb 2024 1 -$988,411 4 10%+ Owner 13 Feb 2024, 21:31
MGX Metagenomi Technologies, LLC 08 Feb 2024 0 $0 3 10%+ Owner 08 Feb 2024, 20:37
IOBT IO Biotech, Inc. 09 Aug 2023 2 +$9,999,997 4 10%+ Owner 11 Aug 2023, 16:31
/report/000120919123042977-novo-holdings-a-s-2023-07-19 Cyteir Therapeutics, Inc. 19 Jul 2023 2 -$280,387 4 10%+ Owner 20 Jul 2023, 20:01
/report/000120919123042670-novo-holdings-a-s-2023-07-14 Cyteir Therapeutics, Inc. 14 Jul 2023 3 -$106,024 4 10%+ Owner 18 Jul 2023, 20:27
/report/000120919123040691-novo-holdings-a-s-2023-06-30 Cyteir Therapeutics, Inc. 30 Jun 2023 1 -$529,288 4 10%+ Owner 03 Jul 2023, 18:29
IRON Disc Medicine, Inc. 28 Jun 2023 1 -$57,625,000 4 10%+ Owner 28 Jun 2023, 17:04
/report/000120919123040129-novo-holdings-a-s-2023-06-26 Cyteir Therapeutics, Inc. 26 Jun 2023 2 -$71,794 4 10%+ Owner 28 Jun 2023, 21:35
OKUR Reneo Pharmaceuticals, Inc. 23 Jun 2023 1 -$709,740 4 10%+ Owner 23 Jun 2023, 19:15
/report/000120919123039545-novo-holdings-a-s-2023-06-21 Cyteir Therapeutics, Inc. 21 Jun 2023 3 -$25,870 4 10%+ Owner 23 Jun 2023, 19:17
/report/000120919123038567-novo-holdings-a-s-2023-06-15 Cyteir Therapeutics, Inc. 15 Jun 2023 3 -$34,019 4 10%+ Owner 20 Jun 2023, 17:53
/report/000120919123037208-novo-holdings-a-s-2023-06-12 Cyteir Therapeutics, Inc. 12 Jun 2023 3 -$13,423 4 10%+ Owner 14 Jun 2023, 20:18
SPRB SPRUCE BIOSCIENCES, INC. 16 Feb 2023 2 +$6,999,360 4 10%+ Owner 21 Feb 2023, 15:19
IRON Disc Medicine, Inc. 29 Dec 2022 0 $0 3 10%+ Owner 03 Jan 2023, 15:42
EWTX Edgewise Therapeutics, Inc. 14 Sep 2022 1 +$4,999,999 4 10%+ Owner 16 Sep 2022, 14:35
/report/000120919122043049-novo-holdings-a-s-2022-07-20 Cyteir Therapeutics, Inc. 20 Jul 2022 1 -$2,700,000 4 10%+ Owner 22 Jul 2022, 18:52
BOLT Bolt Biotherapeutics, Inc. 13 Jul 2022 1 -$1,600,000 4 10%+ Owner 15 Jul 2022, 16:16
/report/000120919122013316-novo-holdings-a-s-2022-02-23 Checkmate Pharmaceuticals, Inc. 23 Feb 2022 3 -$23,067 4 10%+ Owner 25 Feb 2022, 17:21
ACLX Arcellx, Inc. 08 Feb 2022 6 +$12,499,995 4 10%+ Owner 09 Feb 2022, 16:42
ACLX Arcellx, Inc. 03 Feb 2022 0 $0 3 10%+ Owner 03 Feb 2022, 17:04
IOBT IO Biotech, Inc. 09 Nov 2021 4 +$4,550,000 4 10%+ Owner 10 Nov 2021, 18:04
IOBT IO Biotech, Inc. 04 Nov 2021 0 $0 3 10%+ Owner 04 Nov 2021, 17:15
/report/000120919121061795-novo-holdings-a-s-2021-10-26 MINERVA SURGICAL INC 26 Oct 2021 5 +$1,409,940 4 10%+ Owner 27 Oct 2021, 16:31
/report/000120919121061312-novo-holdings-a-s-2021-10-21 MINERVA SURGICAL INC 21 Oct 2021 0 $0 3 10%+ Owner 21 Oct 2021, 19:33
/report/000120919121042786-novo-holdings-a-s-2021-06-22 Cyteir Therapeutics, Inc. 22 Jun 2021 4 +$4,999,986 4 10%+ Owner 23 Jun 2021, 17:18
VERV Verve Therapeutics, Inc. 21 Jun 2021 3 +$6,650,000 4 10%+ Owner 22 Jun 2021, 17:17
/report/000120919121041813-novo-holdings-a-s-2021-06-17 Cyteir Therapeutics, Inc. 17 Jun 2021 0 $0 3 10%+ Owner 17 Jun 2021, 21:43
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 17:18
INGN Inogen Inc 02 Jun 2021 1 -$38,977,600 4 10%+ Owner 03 Jun 2021, 19:21
SPRB SPRUCE BIOSCIENCES, INC. 19 May 2021 1 -$6,602,500 4 10%+ Owner 21 May 2021, 16:32